Protective effect of Nrf2 and catalase in maternal diabetes-induced perinatal hypertension and kidney disease

Diabetes

Volumn 61, Issue 10, 2012, Pages 2400-2402

  Vaziri, Nosratola D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CATALASE; GLUCOSE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HEME OXYGENASE 1; HYDROGEN PEROXIDE; HYDROXYL RADICAL; HYPOCHLOROUS ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE; THIOREDOXIN; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA;

ASTHMA; CHRONIC GRANULOMATOUS DISEASE; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE SEVERITY; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY DISEASE; MATERNAL DIABETES MELLITUS; NONHUMAN; NOTE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; HEME OXYGENASE-1; HYPERTENSION; KIDNEY DISEASES; MALE; NF-E2-RELATED FACTOR 2;

EID: 84866609322     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0764     Document Type: Note

References (23)

1. Li W, Khor TO, Xu C, et al. Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis. Biochem Pharmacol 2008;76:1485-1489
2. Surh YJ, Kundu JK, Na HK. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med 2008;74:1526-1539
3. Cullinan SB, Diehl JA. PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. J Biol Chem 2004;279:20108-20117 (Pubitemid 38623455)
4. Yoh K, Itoh K, Enomoto A, et al. Nrf2-deficient female mice develop lupuslike autoimmune nephritis. Kidney Int 2001;60:1343-1353 (Pubitemid 32960028)
5. Yoh K, Hirayama A, Ishizaki K, et al. Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice. Genes Cells 2008;13:1159-1170
6. Shin DH, Park HM, Jung KA, et al. The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibrosis. Free Radic Biol Med 2010;48:1051-1063
7. Qian M, Liu M, Eaton JW. Transition metals bind to glycated proteins forming redox active "glycochelates": implications for the pathogenesis of certain diabetic complications. Biochem Biophys Res Commun 1998;250:385-389 (Pubitemid 28463887)
8. Young IS, Tate S, Lightbody JH, McMaster D, Trimble ER. The effects of desferrioxamine and ascorbate treatment on oxidative stress in the streptozotocin diabetic rat. Free Radic Biol Med 1995;18:833-840
9. Shah SV, Baliga R, Rajapurkar M, Fonseca VA. Oxidants in chronic kidney disease. J Am Soc Nephrol 2007;18:16-28 (Pubitemid 46053418)
10. Kanwar YS, Nayak B, Lin S, et al. Hyperglycemia: its imminent effects on mammalian nephrogenesis. Pediatr Nephrol 2005;20:858-866 (Pubitemid 40909252)
11. Kanwar YS, Akagi S, Nayak B, et al. Renal-specific oxidoreductase biphasic expression under high glucose ambience during fetal versus neonatal development. Kidney Int 2005;68:1670-1683 (Pubitemid 43169912)
12. Ornoy A. Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy. Reprod Toxicol 2007;24:31-41 (Pubitemid 47042350)
13. Davis JM, Auten RL. Maturation of the antioxidant system and the effects on preterm birth. Semin Fetal Neonatal Med 2010;15:191-195
14. Tran S, Chen YW, Chenier I, et al. Maternal diabetes modulates renal morphogenesis in offspring. J Am Soc Nephrol 2008;19:943-952
15. Zhang SL, Chen YW, Tran S, Chenier I, Hébert MJ, Ingelfinger JR. Reactive oxygen species in the presence of high glucose alter ureteric bud morphogenesis. J Am Soc Nephrol 2007;18:2105-2115 (Pubitemid 47041076)
16. Chen YW, Chenier I, Chang SY, Tran S, Ingelfinger JR, Zhang SL. High glucose promotes nascent nephron apoptosis via NF-kappaB and p53 pathways. Am J Physiol Renal Physiol 2011;300:F147-F156
17. Rieber N, Hector A, Kuijpers T, Roos D, Hartl D. Current concepts of hyperinflammation in chronic granulomatous disease. Clin and Dev Immunol 2012;2012:252460
18. Dworski R, Han W, Blackwell TS, Hoskins A, Freeman ML. Vitamin E prevents NRF2 suppression by allergens in asthmatic alveolar macrophages in vivo. Free Radic Biol Med 2011;51:516-521
19. Kim HJ, Vaziri ND. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Renal Physiol 2010;298:F662-F671
20. Kim HJ, Sato T, Rodríguez-Iturbe B, Vaziri ND. Role of intrarenal angiotensin system activation, oxidative stress, inflammation, and impaired Nrf2 activity in the progression of focal glomerulosclerosis. J Pharmacol Exp Ther 2011;337:583-590
21. Yu M, Li H, Liu Q, et al. Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway. Cell Signal 2011;23:883-892
22. Faraonio R, Vergara P, Di Marzo D, et al. p53 suppresses the Nrf2-dependent transcription of antioxidant response genes. J Biol Chem 2006;281:39776-39784 (Pubitemid 46041781)
23. Chang S-Y, Chen Y-W, Zhao X-P, et al. Catalase prevents maternal diabetes-induced perinatal programming via the Nrf2-HO-1 defense system. Diabetes 2012;61:2565-2574